Xenetic Biosciences (XBIO) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
8 Jan, 2026Opening remarks and agenda
Interim CEO welcomed participants, introduced auditors and legal representatives, and called the meeting to order.
Formal business was to proceed as outlined in the Notice of Annual Meeting and Proxy Statement.
Corporate governance
List of stockholders entitled to vote was made available for examination prior to and during the meeting.
Affidavit confirmed timely mailing of the Notice of Annual Meeting to all stockholders of record.
Inspector of election took an oath to execute duties impartially and will file it with meeting records.
Overview of voting outcomes
Proxies received represented about 42% of outstanding shares, insufficient for a quorum.
Without a quorum, no business could be transacted and no votes could be tallied.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Xenetic Biosciences
- Progressed DNase-based oncology pipeline, increased royalties, and raised cash via public offering.XBIO
Q4 202513 Mar 2026 - DNase I shows promise in overcoming immunotherapy resistance in colorectal cancer models.XBIO
Status Update12 Jan 2026 - Up to $50M in securities may be offered to fund clinical and corporate initiatives amid high development risk.XBIO
Registration Filing16 Dec 2025 - Annual meeting adjourned for lack of quorum; reconvened for January 8, 2026, with voting ongoing.XBIO
Proxy Filing11 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and key governance matters.XBIO
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay proposals.XBIO
Proxy Filing2 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay approval.XBIO
Proxy Filing2 Dec 2025 - Q3 2025 revenue up 67% to $1.03M; $3.9M equity raise extends runway amid strategic review.XBIO
Q3 202513 Nov 2025 - Annual meeting to vote on directors, auditor ratification, and executive pay, with new auditor named.XBIO
Proxy Filing31 Oct 2025